Sonic Healthcare: Better than Swiss chocolate
Morgans
Sonic (SHL, Add, Price Target $24.13 ) has significantly strengthened its Swiss footprint and EU position with the purchase of Switzerland-based Medisupport. We view regulatory approval as likely and the deal as favourable, given both near-term EPS and ROIC accretion along with margin expansion via synergy gains and scale efficiencies. Report Attached visit the Morgans blog for regular Healthcare updates: (VIEW LINK)
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise